Cleerly ISCHEMIA vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cleerly ISCHEMIA

by Cleerly

Rhythm360

by RhythmScience

AI Verdict

Cleerly ISCHEMIA is an AI-powered diagnostic tool that analyzes CCTA scans to detect coronary artery ischemia and characterize plaque, aiding in personalized heart disease diagnosis. In contrast, Rhythm360 is an AI-powered platform designed for aggregating and analyzing cardiac monitoring data from various devices to manage conditions such as hypertension, heart failure, and arrhythmias. While both serve cardiology, Cleerly focuses on diagnostic imaging analysis, whereas Rhythm360 specializes in remote patient monitoring and data management.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if your primary goal is to non-invasively assess the likelihood of coronary artery ischemia and characterize coronary plaque burden from CCTA scans. This tool is ideal for physicians needing AI-powered precision to enhance diagnosis and personalize treatment plans for patients with suspected or known coronary artery disease, leveraging detailed vessel-level analysis and FFR estimation.

View Cleerly ISCHEMIA →

Choose Rhythm360 if…

Choose Rhythm360 if your practice requires a comprehensive, vendor-neutral platform to aggregate and manage cardiac monitoring data from diverse devices for ongoing patient care. This solution is best suited for reducing alert fatigue, streamlining workflows for hypertension, heart failure, and rhythm management, and automating CPT code documentation for remote patient monitoring services.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cleerly ISCHEMIA	Rhythm360
Pricing	Unknown	Flexible pricing model that scales with clinic size and platform usage.
Deployment	Web-based solution	Cloud-based SaaS platform
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Rhythm360 offers a HIPAA-compliant mobile application for clinicians and features AI-driven alert triage, which significantly reduces alert fatigue and streamlines daily workflows. While Cleerly ISCHEMIA provides comprehensive web-based reports and 3D models, Rhythm360's focus on mobile access and workflow efficiency for active patient management gives it an edge in overall usability for clinicians.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA is an FDA-cleared AI tool that provides non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization from CCTA scans. This direct diagnostic capability for personalized diagnosis and treatment planning for heart disease, backed by FDA clearance, demonstrates a high and specific clinical value. Rhythm360 offers value in managing existing conditions, but Cleerly's diagnostic impact is more directly tied to critical clinical decision-making.

Pricing & Value

Tie

Both tools lack transparent pricing details, making a direct comparison difficult. Cleerly ISCHEMIA's pricing 'varies by provider,' while Rhythm360 has a 'flexible pricing model that scales with clinic size and platform usage' but is also described as having 'premium pricing.' Without concrete figures or more detailed value propositions tied to cost, it's impossible to definitively pick a winner.

Enterprise Readiness

Rhythm360

Rhythm360 demonstrates superior enterprise readiness with extensive bi-directional EHR integrations (Epic, Cerner, Athenahealth, etc.), vendor-neutral data aggregation from all major OEMs, and automated CPT code documentation and billing. These features are crucial for seamless integration into large healthcare systems and optimizing operational workflows. Cleerly ISCHEMIA, while HIPAA-compliant and FDA-cleared, has more limited integration details provided.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA's ability to perform AI-enabled CCTA analysis for non-invasive fractional flow reserve (FFR) estimation and detailed vessel-level ischemia likelihood determination represents a significant innovation in non-invasive cardiac diagnostics. While Rhythm360's AI-driven data aggregation and alert triage are also innovative, Cleerly's specific diagnostic capabilities for a critical cardiac condition push the boundaries of current imaging analysis.

Support & Docs

Rhythm360

Rhythm360 explicitly offers optional 24/7/365 oversight by certified cardiac technicians (CCTs), indicating a robust support structure for its users. In contrast, the provided information for Cleerly ISCHEMIA does not include any details regarding support or documentation. This clear offering gives Rhythm360 the advantage in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cleerly ISCHEMIA	Rhythm360
Tool Name	Cleerly ISCHEMIA	Rhythm360
Company	Cleerly	RhythmScience
Primary Focus	Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease.	Unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Core Data Analyzed	CCTA scans	Cardiac monitoring data from various devices (e.g., Medtronic, Boston Scientific, Abbott, Biotronik)
Key Output/Insight	Non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood, coronary plaque characterization, stenosis severity assessment, 3D digital models, comprehensive interactive web-based reports.	AI-driven alert triage (80% faster response times, reduces alert fatigue), predictive algorithms for Heart Failure Management, GDMT optimization.
EHR Integration	Integration with PowerScribe via API	Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity)
Automated Billing/Coding	Not specified	Automated CPT code documentation and billing (e.g., 93298, 93299, 99454, 99453, 99457)

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Rhythm360.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool specifically integrate into existing cardiology workflows, differentiating between diagnostic imaging interpretation and ongoing patient management?

Cleerly ISCHEMIA integrates with CCTA interpretation workflows, providing AI-powered analysis for non-invasive ischemia detection and personalized diagnosis and treatment planning for heart disease. Rhythm360 integrates with remote monitoring and chronic disease management workflows by unifying data from various cardiac devices, triaging alerts, and providing insights for hypertension, heart failure, and rhythm management.

What is the depth of EHR integration for each solution, particularly concerning bi-directional data exchange and automated clinical documentation?

Rhythm360 offers comprehensive bi-directional EHR integration with major systems like Epic and Cerner, including automated CPT code documentation and billing. Cleerly ISCHEMIA integrates with PowerScribe via API, primarily for transferring CCTA analysis results into reporting systems.

What specific clinical insights and accuracy metrics can physicians expect from each tool's AI algorithms, and how do these directly support clinical decision-making?

Cleerly ISCHEMIA provides vessel-level ischemia likelihood, coronary plaque characterization, and stenosis severity assessment from CCTA scans to aid diagnostic decisions and treatment planning, with its accuracy validated against invasive FFR. Rhythm360 offers AI-driven alert triage for faster response times and predictive algorithms for heart failure management to support ongoing patient care and GDMT optimization, with reported 80% faster response times for critical alerts.

What is the expected learning curve for physicians to effectively utilize each tool's advanced features, and what training resources are available?

Cleerly ISCHEMIA requires familiarity with interpreting comprehensive interactive web-based reports and 3D digital models derived from CCTA analysis. Rhythm360 involves learning to navigate a unified platform for aggregated cardiac monitoring data and utilizing AI-driven alert triage and management features to reduce alert fatigue, with implementations typically completing in days or weeks including staff education.

For multi-site cardiology practices, what are the key considerations for implementing and scaling each solution across different clinical environments?

Cleerly ISCHEMIA, as a web-based platform with data transfer via Cleerly Proxy, would require considerations for secure data transmission from various imaging centers. Rhythm360, a cloud-based SaaS platform with vendor-neutral data aggregation and bi-directional EHR integration, is designed to scale by unifying data from diverse monitoring devices across multiple sites and clinic sizes.

What audit-trail capabilities are built into each platform to ensure accountability and track clinical actions or AI-generated insights?

Rhythm360 maintains HIPAA-compliant records of monitoring activities and patient communications, with Twilio-powered communication tools logging calls and messages inside the patient record, creating a clear audit trail. While not explicitly detailed for Cleerly ISCHEMIA, robust audit-trail features are generally crucial for clinical AI platforms to track user actions, data modifications, and the application of AI-driven insights for regulatory compliance and clinical oversight.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly ISCHEMIA or Rhythm360

Backers

Who funded each tool's parent company.